Microdosing a GLP-1 for maintenance after weight loss

Can a lower dose hold what a standard dose achieved? What the evidence on stopping and maintenance actually shows, and how clinicians approach the question.

One of the most reasonable questions in this whole area: if a GLP-1 did something and you would rather not stay on a full dose indefinitely, can a smaller one hold it? The question is good. The evidence is incomplete, and it is worth being clear about which part is which.

Why does maintenance come up at all?

Because the published trials of the approved products measured what happened while people were taking them, and the withdrawal and extension studies that followed indicate the effects are tied to continued treatment rather than permanent after it. That is the finding behind every conversation about tapering, maintenance and stopping. It is also why 'how long do I stay on this' is a question to ask at the start rather than at the end.

Does a lower maintenance dose work?

Lower-than-standard dosing has not been studied the way the approved schedule has. The published trials tested the titration schedules on the FDA-approved products' labels, so their results describe those regimens — not a lower dose, and not a compounded preparation.

Specifically, no trial has randomised people who responded on a standard dose to either stay there or drop to a defined lower dose, and then followed them. Until something like that exists, the honest answer is that a lower maintenance dose is a clinical judgment with a plausible rationale and no published schedule behind it.

How do clinicians approach it?

• From your check-ins, not from a chart: what changed, what has held, what side effects you have had, and what else is going on in your health.
• Gradually. A dose is usually moved in steps with time to see what happens, rather than cut at once.
• With a plan for what happens if things move in the wrong direction, including going back up.
• In the context of everything else that supports maintenance — eating, protein, activity, sleep — which does not stop mattering because a medication is involved.

What are the risks of dropping the dose?

The main one is simply that it may not hold, which is manageable if you are being followed and are not treating the change as permanent. The second is assuming a smaller dose means you can stop paying attention: the labelled warnings still apply, screening still applies, and anything unexpected still goes to your care team. The third is doing it yourself. Stretching doses, skipping weeks or rationing a vial to make it last is not a maintenance plan — it is an unmonitored dose change, and it is the one version of this that is genuinely risky.

What does this look like at GLP?

A licensed clinician decides whether a lower-dose program is appropriate for you, and adjusts from your check-ins over time. Both the standard and microdose programs use compounded medication. Compounded medications are not FDA-approved and are not reviewed by the FDA for safety, effectiveness, or quality. You can message your care team between check-ins, which is where a maintenance conversation belongs.

This article is educational and is not a substitute for personalized medical advice. Whether any medication is appropriate for you is a decision for a licensed clinician who has reviewed your health history.